BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,090 filers reported holding BAXTER INTL INC in Q2 2021. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $25,000 | +4.2% | 300 | -0.7% | 0.00% | -33.3% |
| Q4 2020 | $24,000 | 0.0% | 302 | +0.3% | 0.00% | -25.0% |
| Q3 2020 | $24,000 | -90.9% | 301 | +2050.0% | 0.00% | +300.0% |
| Q1 2017 | $263,000 | 0.0% | 14 | +16.7% | 0.00% | -66.7% |
| Q4 2016 | $263,000 | +171.1% | 12 | -99.4% | 0.00% | -75.0% |
| Q3 2016 | $97,000 | -57.1% | 2,029 | -59.4% | 0.01% | -55.6% |
| Q2 2016 | $226,000 | -31.9% | 4,995 | -38.3% | 0.03% | +2600.0% |
| Q1 2016 | $332,000 | -21.1% | 8,091 | -26.7% | 0.00% | -98.3% |
| Q4 2015 | $421,000 | -12.3% | 11,031 | -24.5% | 0.06% | -43.7% |
| Q3 2015 | $480,000 | -69.7% | 14,604 | -35.6% | 0.10% | -39.1% |
| Q2 2015 | $1,585,000 | +2.1% | 22,662 | 0.0% | 0.17% | +5.0% |
| Q1 2015 | $1,552,000 | -23.2% | 22,662 | -17.9% | 0.16% | -24.1% |
| Q4 2014 | $2,022,000 | -10.5% | 27,589 | -12.3% | 0.21% | -10.5% |
| Q3 2014 | $2,258,000 | -21.0% | 31,458 | -20.4% | 0.24% | -19.9% |
| Q2 2014 | $2,859,000 | -10.2% | 39,544 | -8.6% | 0.30% | -7.2% |
| Q1 2014 | $3,183,000 | -35.0% | 43,268 | -38.6% | 0.32% | -26.3% |
| Q4 2013 | $4,899,000 | -17.7% | 70,436 | -22.3% | 0.43% | -18.8% |
| Q3 2013 | $5,956,000 | -10.5% | 90,670 | -5.7% | 0.53% | -5.0% |
| Q2 2013 | $6,658,000 | – | 96,108 | – | 0.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |